Health Condition 1: K30- Functional dyspepsia
Conditions
Interventions
Intervention1: Habb-e-Pachlona: 500g-1g twice daily orally after meals with water for 2 weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine (CCRUM), New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 18-60 2. Patients meeting the Rome III diagnostic criteria for PDS
Exclusion criteria
Exclusion criteria: 1. Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion based on clinical diagnosis. 2. Having overlap syndrome combined with gastro esophageal reflux disease or irritable bowel syndrome 3. Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.) 4. Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness 5. History of surgery related with the gastrointestinal tract more than six months ago 6. Taking drugs which may affect the gastro intestinal tract, such as non-steroidal anti-inflammatory drugs and aspirin 7. Known Allergy to the experimental medications 8. Pregnant and breastfeeding 9. Refusing to sign the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy will be assessed on the basis of assessment of patients clinically i.e. improvement in sign and symptomsTimepoint: At baseline and 14th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and 14th day | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed